Overexpression of SET in three different colon cancer cell lines, SW480, HT-29 and LS513, resulted in increasing resistance to oxaliplatin and 5-FU, and silencing SET via siRNA oppositely enhanced their sensitivity to this chemoregimen. This evidence concerns the gene SET and malignant colon neoplasm.